Bacterial pathogens that colonize
wounds form biofilms, which protect the bacteria from the effect of host immune response and
antibiotics. This study examined the effectiveness of newly synthesized
zinc sulfide in inhibiting biofilm development by Staphylococcus aureus ( S. aureus) strains.
Zinc sulfide (ZnS) was anaerobically biosynthesized to produce CompA, which was further processed by cryomilling to maximize the antibacterial properties to produce
CompB. The effect of the two compounds on the S. aureus strain AH133 was compared using zone of inhibition assay. The compounds were formulated in a
polyethylene glycol cream. We compared the effect of the two compounds on biofilm development by AH133 and two methicillin-resistant S. aureus clinical isolates using the in vitro model of
wound infection. Zone of inhibition assay revealed that
CompB is more effective than CompA. At 15 mg/application, the formulated cream of either compound inhibited biofilm development by AH133, which was confirmed using confocal
laser scanning microscopy. At 20 mg/application,
CompB inhibited biofilm development by the two methicillin-resistant S. aureus clinical isolates. To further validate the effectiveness of
CompB, mice were treated using the murine model of
wound infection. Colony forming cell assay and in vivo live imaging results strongly suggested the inhibition of S. aureus growth.